In plain words
One trial found that taurine did not change insulin sensitivity in 20 men at raised risk of type 2 diabetes. In a second trial, taurine was associated with higher adiponectin, a different measure, than placebo in 16 obese women. A pooled analysis that may include these trials found lower fasting insulin.
The short answer
Two randomized trials, both lasting 8 weeks, point different ways: Brøns and colleagues (2004) gave 1.5 g a day to 20 men at raised diabetes risk and found no effect on insulin sensitivity, while in Rosa and colleagues (2013), 3 g a day with nutritional counseling in 16 obese women was associated with higher adiponectin than placebo. A 2020 review by Wu and colleagues reports a study that found better insulin sensitivity in people with high blood sugar. Tzang and colleagues (2024) found lower fasting insulin, a pooled estimate that may include the trials above. Certainty is very low, because both trials are small and measured different outcomes.
Where the evidence sits
Insulin markers improved
No effect found
■ measured by the source's own study · ◪ pooled analysis, may overlap studies counted here · □ reported, reviewed or argued, no new data
Who says what
| Source | Finding | Design | People | Dose and length | Funding and independence |
|---|---|---|---|---|---|
| Brøns et al., 2004 | No effect on insulin sensitivity | Randomized trial | 20 men at raised diabetes risk | 1.5 g a day, 8 weeks | Not in ledger |
| Rosa et al., 2013 | Higher adiponectin than placebo | Randomized, placebo-controlled | 16 obese women | 3 g a day plus counseling, 8 weeks | Not in ledger |
| Tzang et al., 2024 | Lower fasting insulin and HOMA index | Meta-analysis of randomized trials | Not in ledger | Not in ledger | Not in ledger |
| Wu et al., 2020 | Better insulin sensitivity with high blood sugar | Review describing another group's study | Not in ledger | Not in ledger | Not in ledger |
| Ripps et al., 2012 | No effect on insulin sensitivity | Review that appears to describe the Brøns trial | 20 | 1.5 g, 8 weeks | Not in ledger |
No effect on insulin sensitivity
Higher adiponectin than placebo
Lower fasting insulin and HOMA index
Better insulin sensitivity with high blood sugar
No effect on insulin sensitivity
Did insulin sensitivity change when it was measured directly?
Brøns and colleagues (2004) gave 20 men at increased risk of type 2 diabetes 1.5 g of taurine a day for 8 weeks in a randomized trial. They concluded:
Daily supplementation with 1.5 g taurine for 8 weeks had no effect on insulin secretion or sensitivity
Ripps and colleagues (2012), in a review, describe a study of 20 obese people with a genetic predisposition to type 2 diabetes, given 1.5 g for 8 weeks, with the same result. It appears to describe the Brøns trial, so it is one measurement, not two.
What did the trial in obese women measure?
Rosa and colleagues (2013) compared taurine with placebo in 16 obese women taking 3 g a day for 8 weeks alongside nutritional counseling. They report adiponectin rather than insulin sensitivity itself:
Eight weeks of taurine supplementation associated with nutritional counseling is able to increase adiponectin levels
The ledger has no insulin or HOMA result from this trial.
What do the pooled analysis and the reviews add?
Tzang and colleagues (2024) combined randomized trials and found lower fasting insulin and a lower HOMA index with taurine than with control. This is a pooled estimate that may include the trials above, and the ledger has no trial count, n, dose or duration for it:
fasting insulin levels (WMD: −1.521 mU/L, 95% CI: −2.591 to −0.451, p = 0.005)
Wu and colleagues (2020) report in a review that a study by Sarkar and colleagues found better whole-body insulin sensitivity in people with high blood sugar. The ledger has no n, dose or duration for that study.
Why the sources disagree
The studies measured different things: insulin secretion and sensitivity (Brøns), adiponectin (Rosa), and fasting insulin and the HOMA index (Tzang, a pooled estimate that may include both trials). The people differ: men at increased diabetes risk, obese women, and, in the study Wu describes, people with high blood sugar. Both trials lasted 8 weeks, with 20 people at 1.5 g a day and 16 at 3 g a day plus nutritional counseling. Two of the five sources are reviews of other groups' work, and the ledger has no funding details.
What would settle it
An independent, pre-registered trial in at least 100 adults, giving 3 g of taurine a day or placebo for at least 12 weeks with no other change in diet. It would measure insulin sensitivity directly, plus fasting insulin, the HOMA index and adiponectin, and report men, women and people with high blood sugar separately. A matching result from a second group would raise certainty.
How this page was made
The 5 sources come from a search of PubMed records on taurine; studies in animals, cells and disease groups such as heart failure were left out. Every claim was copied word for word from its source into the Longevity Circle ledger and checked against the original text, and a person approved each one. Certainty follows the GRADE levels used in medical reviews. Drafting was assisted by AI.
The ledger holds only 3 studies on this question.
Changelog: 23 Sep 2026, first version, 5 sources.
